Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > Lucid Psycho treating alcoholism could be a winner
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(41)
•••
Comment by JAKPUG4LIFEon Jan 13, 2023 11:51am
52 Views
Post# 35221303

RE:RE:RE:Lucid Psycho treating alcoholism could be a winner

RE:RE:RE:Lucid Psycho treating alcoholism could be a winner
Bigmac4000 wrote: Am i the only one here that wants to address the elaphant in the room? We are approx 60+ days from delisting and we are opening an office in Australia and hiring more "doctors" but ummmmm we are about to be delisted from the great NASDAQ with all the institutional investors. You know, the thing we sunk millions into and wasted millions to ring the bell. 

What is the game plan? 
R/S is my assumption. 
Would we not be better off wasting our money on share buy back to get us above 1$? 
I looked at the website David posted about the clinical trials and oooooh guess what? Just like the COVID trials, so far not one person is registered for the trial program. 
Is the goal to find people in Australia down on their luck looking for some trial money? A country of 350 million in USA and they cant find one person lol. 
I see the markets reacted to the Australia news as expected. 



Game plan= Rinse/Repeat
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities